Results 1 to 10 of about 22,920 (247)

Calidad de prescripción de montelukast en pacientes adultos: Estudio en tres farmacias comunitarias de la Comunidad Valenciana [PDF]

Farmacéuticos Comunitarios, 2014
Introducción: El objetivo de este trabajo es analizar la utilización de montelukast en adultos desde tres farmacias comunitarias. Material y métodos: Estudio descriptivo, observacional en tres farmacias comunitarias (enero 2009 - febrero 2013) en ...
Peris Molina MT, Ferrer Estrela F, d’Ocón Navaza MP, Úbeda Pascual A.   +3 more
doaj   +2 more sources

Montelukast Prevents Mice Against Acetaminophen-Induced Liver Injury [PDF]

Frontiers in Pharmacology, 2019
Acetaminophen (APAP) is a widely used over-the-counter antipyretic and analgesic drug. Overdose of APAP is the leading cause of hospital admission for acute liver failure.
Shiyun Pu, Qinhui Liu, Yanping Li, Rui Li, Tong Wu, Zijing Zhang, Cuiyuan Huang, Xuping Yang, Jinhan He, Jinhan He   +9 more
doaj   +2 more sources

Montelukast treats Streptococcus pneumoniae-induced sepsis via antibacterial and anti-inflammatory activities [PDF]

Microbiology Spectrum
Streptococcus pneumoniae is a leading causative pathogen of community-acquired pneumonia and sepsis. The increasing prevalence of antibiotic resistance among S. pneumoniae strains poses a major challenge to conventional antibiotic therapies.
Wei Cao, Dongjun Xu, Huijie Yu, Xuning Shen   +3 more
doaj   +2 more sources

Effectiveness, safety, and cost-effectiveness of fixed-dose combination of montelukast–bilastine versus montelukast–levocetirizine in allergic rhinitis: A prospective, randomized, open-label, parallel-group study [PDF]

Perspectives in Clinical Research
Introduction: Several fixed-dose combinations (FDCs) have been available for the treatment of allergic rhinitis (AR), of which montelukast and levocetirizine is one of the highly prescribed FDC.
Ganesh Natthuji Dakhale, Chaitali A. Chindhalore, Mohit Kumar, Vijay Bidkar   +3 more
doaj   +2 more sources

Montelukast: risk of mental disorders vs. efficacy–a meta-analysis [PDF]

Frontiers in Pharmacology
BackgroundMontelukast, a selective leukotriene receptor antagonist, is widely used in the treatment of bronchial asthma and allergic rhinitis (AR). Although it is a well-tolerated drug, there are reports of possible central nervous system side effects ...
Marharyta Sobczak, Rafał Pawliczak
doaj   +2 more sources

Montelukast alleviates neuroinflammation and improves motor functions in the line 61 model of Parkinson's disease: An exploratory study [PDF]

Neurotherapeutics
Parkinson's disease (PD) is a neurodegenerative movement disorder of high global burden. Uncertainties regarding its exact etiology have been hindering the development of curative therapies.
Katharina Strempfl, Marco Zattoni, Heike Mrowetz, Michael S. Unger, Nikolaos Schörghofer, Barbara Altendorfer, Jörg Neddens, Stefanie Flunkert, Birgit Hutter-Paier, Yachao He, Johan Wallin, Rodolphe W. Poupardin, Frank Pietrantonio, Nadine Paiement, Horst Zerbe, Thomas Felder, Per Svenningsson, Ludwig Aigner   +17 more
doaj   +2 more sources

Efficacy of Montelukast in Allergic Rhinitis Treatment: A Systematic Review and Meta-Analysis [PDF]

Drugs, 2020
Madhusudhan Krishnamoorthy, Norhayati Mohd Noor, Norhafiza Mat Lazim Mbbs   +2 more
exaly   +2 more sources

The Impact of Montelukast Duration on the Risk of Neuropsychiatric Disorders in Children with Asthma: A Population-Based Cohort Study [PDF]

Pharmaceuticals
Background/Objectives: Asthma is one of the most common chronic diseases in children, and montelukast is widely prescribed to manage symptoms. However, concerns have emerged regarding its potential association with neuropsychiatric disorders.
Wei-Te Lei, Chien-Yu Lin, Szu-Hung Chu, Li-Ching Fang, Yu-Hsuan Kao, Po-Li Tsai, Yu-Wen Lin, Fung-Chang Sung, Shu-I Wu   +8 more
doaj   +2 more sources

Effect of montelukast on remission maintenance in patients with ulcerative colitis: a Randomized, double-blind controlled clinical trial [PDF]

BMC Gastroenterology
Background Considering the role of leukotrienes in inflammatory pathways, and owing to the anti-leukotrienes effect of montelukast, in the present clinical trial, we aimed to assess the effect of montelukast on remission maintenance in patients with ...
Kourosh Masnadi Shirazi, Mehran Nezam Diba, Arman Masnadi Shirazinezhad, Zeinab Nikniaz   +3 more
doaj   +2 more sources

Reduction of Vancomycin-Associated Acute Kidney Injury With Montelukast. [PDF]

J Infect Dis
Teran NS, Hudson CS, Phe K, Wang Y, Zhang Y, Chen H, Nigo M, Tam VH.   +7 more
europepmc   +3 more sources